RXST
RxSight, Inc. · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -8.3% ·
share flow -19.9% ·
net new positions -9.1%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 70 | -7 | 30.76M | $148.37M | +3 | −9 |
| Q1 2026 | 78 | +10 | 29.02M | $178.70M | +11 | −1 |
| Q4 2025 | 68 | 0 | 28.07M | $292.47M | +1 | −1 |
| Q3 2025 | 17 | 0 | 14.88M | $133.76M | +1 | −1 |
| Q2 2025 | 14 | 0 | 12.67M | $164.75M | +1 | −1 |
| Q1 2025 | 11 | -1 | 4.08M | $103.15M | — | −1 |
| Q4 2024 | 12 | 0 | 5.10M | $175.38M | — | — |
| Q3 2024 | 11 | -1 | 3.15M | $155.64M | — | −1 |
| Q2 2024 | 12 | — | 2.73M | $164.29M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 898.67K | +0.9% | $22.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Millennium Management ✦ | 897.85K | -10.9% | $22.67M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 863.26K | +3.9% | $21.80M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 863.26K | +3.9% | $21.80M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 451.60K | +24.9% | $11.40M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Baillie Gifford ✦ | 392.23K | -1.7% | $9.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Baillie Gifford ✦ | 392.23K | -1.7% | $9.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Baillie Gifford ✦ | 392.23K | -1.7% | $9.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Baillie Gifford ✦ | 392.23K | -1.7% | $9.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 230.22K | -76.8% | $5.81M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 230.22K | -76.8% | $5.81M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Point72 Asset Management ✦ | 154.01K | -60.7% | $3.89M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 118.89K | -6.6% | $3.00M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 38.31K | -23.6% | $967,253 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 38.31K | -23.6% | $967,253 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 38.31K | -23.6% | $967,253 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 38.31K | -23.6% | $967,253 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 38.31K | -23.6% | $967,253 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 22.00K | +129.9% | $555,500 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 17.75K | +9.7% | $449,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Arrowstreet Capital | $769,012 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 162 holders, 37.72M shares, $223.80M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.